Overview

A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus

Status:
NOT_YET_RECRUITING
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate LY3549492 in Chinese participants with type 2 diabetes. Participation in the study will last about 18 weeks.
Phase:
PHASE1
Details
Lead Sponsor:
Eli Lilly and Company